MANIPULATION OF THE MIR-16/FGF-1 AXIS REDUCES PROFIBROTIC, PROLIFERATIVE, AND INFLAMMATORY PHENOTYPES IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)

被引：0
|
作者：
O'Brien, April [1 ]
White, Tori [2 ]
Kyritsi, Konstantina [3 ]
Francis, Heather L. [4 ]
Zhou, Tianhao [1 ]
Chakraborty, Sanjukta [2 ]
Meng, Fanyin [3 ]
Alpini, Gianfranco [5 ]
Glaser, Shannon S. [1 ]
机构：
[1] Texas A&M Univ, College Stn, TX 77843 USA
[2] Texas A&M Univ, Med Physiol, Hlth Sci Ctr, College Stn, TX 77843 USA
[3] Indiana Univ, Dept Med, Bloomington, IN 47405 USA
[4] Indiana Univ, Bloomington, IN 47405 USA
[5] Indiana Univ, Hepatol & Gastroenterol 1, Bloomington, IN 47405 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
496
引用
收藏
页码：309A / 310A
页数：2
相关论文
共 37 条
  • [31] Anti-inflammatory and Antifibrotic Activity of NGM282, A Novel Variant of FGF19, in an Mdr2-Deficient Mouse Model of Primary Sclerosing Cholangitis
    Ling, Lei
    Zhou, Mei
    Yang, Hong
    Learned, Marc
    Rossi, Stephen
    DePaoli, Alex M.
    Tian, Hui
    HEPATOLOGY, 2015, 62 : 309A - 309A
  • [32] PROLONGED ADMINISTRATION OF MELATONIN TO THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSIS CHOLANGITIS (PSC) DECREASES BILIARY SENESCENCE AND LIVER FIBROSIS THROUGH RESTORATION OF THE CIRCADIAN RHYTHM.
    Ceci, Ludovica
    Wu, Nan
    Francis, Heather L.
    Chen, Lixian
    Zhou, Tianhao
    Kennedy, Lindsey
    Kyritsi, Konstantina
    Grumbles, Kassidy
    Rivosecchi-Fulton, Jessica
    Meadows, Vik
    Wu, Chaodong
    Kundu, Debjyoti
    Meng, Fanyin
    Franchitto, Antonio
    Gaudio, Eugenio
    Onori, Paolo
    Mancinelli, Romina
    Alpini, Gianfranco
    Glaser, Shannon S.
    GASTROENTEROLOGY, 2020, 158 (06) : S1309 - S1309
  • [33] LONG-TERM MELATONIN TREATMENT OF THE MDR2<sup<-/-</-/-) MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC) REDUCES PERIBILIARY INFLAMMATION AND OXIDATIVE STRESS THROUGH
    Ceci, Ludovica
    Kennedy, Lindsey
    Francis, Heather L.
    Chen, Lixian
    Wu, Nan
    Zhou, Tianhao
    Meng, Fanyin
    Kundu, Debjyoti
    Kyritsi, Konstantina
    Meadows, Vik
    Ekser, Burcin
    Franchitto, Antonio
    Grumbles, Kassidy
    Onori, Paolo
    Mancinelli, Romina A.
    Gaudio, Eugenio
    Glaser, Shannon S.
    Alpini, Gianfranco
    HEPATOLOGY, 2020, 72 : 250A - 251A
  • [34] CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2-/- mouse model
    Barashi, Neta
    Segal, Michal
    Aharon, Arnon
    Katav, Avi
    Mor, Adi
    Mishalian, Inbal
    Olam, Devorah
    Peled, Amnon
    Saffioti, Francesca
    Thorburn, Douglas
    JOURNAL OF HEPATOLOGY, 2020, 73 : S486 - S486
  • [35] KNOCKOUT OF THE SUBSTANCE P/NEUROKININ-1 RECEPTOR (SP/NK-1R) AXIS REDUCES LIVER FIBROSIS AND BILIARY DAMAGE IN THE MURINE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Giang, Thao
    Zhou, Tianhao
    Venter, Julie
    White, Tori
    Wu, Nan
    Meng, Fanyin
    Onori, Paolo
    Gaudio, Eugenio
    Franchitto, Antonio
    Bennett, Morgan
    Alpini, Gianfranco
    Glaser, Shannon
    GASTROENTEROLOGY, 2018, 154 (06) : S1095 - S1095
  • [36] Inhibition of H2 histamine receptor by Vivo-Morpholino treatment decreases mast cell activation, large biliary proliferation, angiogenesis, fibrosis and inflammation in the Mdr2-/- mouse model of primary sclerosing cholangitis
    Kennedy, Lindsey
    Demieville, Jennifer
    Hargrove, Laura
    Meng, Fanyin
    Alpini, Gianfranco
    Smith, Steven
    Francis, Heather L.
    HEPATOLOGY, 2017, 66 : 110A - 110A
  • [37] Mast Cells Contribute to Hepatic Neurokinin1 Receptor Signaling, Subsequent Biliary Damage and Peribiliary Fibrosis Via TGF-β1 Signaling in MDR2-/- Mouse Model of Primary Scelrosing Cholangitis
    Kundu, Debjyoti
    Zhou, Tianhao
    Meadows, Vik
    Kennedy, Lindsey
    Ceci, Ludovica
    Kyritsi, Konstantina
    Glaser, Shannon
    Alpini, Gianfranco
    Francis, Heather
    FASEB JOURNAL, 2022, 36
1234